Sirintorn R. Mann, PA-C

Sirintorn Mann practices at John Muir Physician Network in Concord, California.

Sirintorn Mann's NPI, 1982608576, was assigned on June 10, 2005. Sirintorn Mann holds California license PA16643.

Sirintorn Mann's primary practice is John Muir Physician Network, at 2700 Grant St, Concord, CA 94520 in Contra Costa County. The practice phone is (925) 296-9872.

Sirintorn Mann's primary practice is John Muir Physician Network in Concord, California. Sirintorn Mann is also affiliated with Concord Medical Center. The medical group on file is John Muir Medical Group. Dmand AI also links Sirintorn Mann to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sirintorn Mann practices, 3 sites in all. Vendor and product names are available with a free account.

Physician assistant is Sirintorn Mann's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Sirintorn Mann is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Sirintorn Mann is licensed in California.

Dmand AI lists diabetic emergency, osteoporosis and vitamin d deficiency among the conditions Sirintorn Mann treats.

CMS data shows 1,026 Medicare services from Sirintorn Mann across 8 procedure codes in 2024, for 124 Medicare patients. Medicare paid $33,831 for them. Every service was in an office.

CMS counts 124 Medicare patients who saw Sirintorn Mann in 2024. The largest group is 65 to 74, with 59 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Sirintorn Mann's median patient age at 67, with 66% women.

In 2024, Sirintorn Mann wrote 1,219 Medicare Part D claims for 233 patients. 42% of them were for generic drugs. CMS names the drug for 971 of them, across 28 drugs with 11 or more claims each, at $524,686 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Sirintorn Mann for performance year 2024, reported as part of a group. Sirintorn Mann accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Sirintorn Mann as offering telehealth.

CMS Open Payments shows 43 general payments to Sirintorn Mann from 13 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 96% of the total. Dexcom, Inc. paid the most, $252.